Beijing Cost Of Revenue vs Operating Income Analysis

300858 Stock   16.47  0.25  1.54%   
Beijing Scitop financial indicator trend analysis is way more than just evaluating Beijing Scitop Bio prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Beijing Scitop Bio is a good investment. Please check the relationship between Beijing Scitop Cost Of Revenue and its Operating Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beijing Scitop Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Cost Of Revenue vs Operating Income

Cost Of Revenue vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Beijing Scitop Bio Cost Of Revenue account and Operating Income. At this time, the significance of the direction appears to have strong relationship.
The correlation between Beijing Scitop's Cost Of Revenue and Operating Income is 0.74. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Operating Income in the same time period over historical financial statements of Beijing Scitop Bio, assuming nothing else is changed. The correlation between historical values of Beijing Scitop's Cost Of Revenue and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Beijing Scitop Bio are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Cost Of Revenue i.e., Beijing Scitop's Cost Of Revenue and Operating Income go up and down completely randomly.

Correlation Coefficient

0.74
Relationship DirectionPositive 
Relationship StrengthSignificant

Cost Of Revenue

Cost of Revenue is found on Beijing Scitop Bio income statement and represents the costs associated with goods and services Beijing Scitop provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Operating Income

Operating Income is the amount of profit realized from Beijing Scitop Bio operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Beijing Scitop Bio is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.
Most indicators from Beijing Scitop's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Beijing Scitop Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beijing Scitop Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
The current year's Tax Provision is expected to grow to about 11.7 M, whereas Selling General Administrative is forecasted to decline to about 27.9 M.
 2021 2022 2023 2024 (projected)
Gross Profit183.5M191.9M163.3M174.1M
Total Revenue364.6M369.2M299.2M349.6M

Beijing Scitop fundamental ratios Correlations

0.050.241.0-0.780.910.940.010.790.80.70.780.2-0.420.70.590.550.64-0.89-0.70.970.850.960.890.781.0
0.050.620.050.3-0.16-0.04-0.120.49-0.36-0.37-0.130.010.51-0.250.53-0.540.520.180.390.210.290.12-0.17-0.280.06
0.240.620.23-0.250.240.140.110.510.120.090.290.06-0.040.040.44-0.070.84-0.140.160.350.230.160.110.090.26
1.00.050.23-0.780.910.940.020.790.80.70.780.2-0.420.70.590.550.63-0.9-0.70.970.850.960.890.781.0
-0.780.3-0.25-0.78-0.78-0.83-0.41-0.52-0.76-0.61-0.62-0.420.46-0.48-0.22-0.53-0.450.850.78-0.72-0.46-0.63-0.91-0.62-0.77
0.91-0.160.240.91-0.780.86-0.060.680.960.890.910.07-0.750.870.530.790.61-0.91-0.680.870.770.840.810.940.92
0.94-0.040.140.94-0.830.860.210.780.760.590.630.44-0.380.620.60.470.49-0.96-0.80.930.790.880.970.720.93
0.01-0.120.110.02-0.41-0.060.210.21-0.14-0.32-0.240.870.29-0.45-0.18-0.38-0.17-0.25-0.490.1-0.29-0.20.32-0.31-0.03
0.790.490.510.79-0.520.680.780.210.490.350.560.43-0.140.430.720.130.7-0.75-0.560.890.80.750.680.490.78
0.8-0.360.120.8-0.760.960.76-0.140.490.960.92-0.06-0.870.930.340.920.51-0.84-0.650.710.680.760.750.980.82
0.7-0.370.090.7-0.610.890.59-0.320.350.960.95-0.3-0.920.940.240.970.48-0.68-0.490.590.590.670.570.960.72
0.78-0.130.290.78-0.620.910.63-0.240.560.920.95-0.23-0.790.870.320.840.64-0.7-0.50.710.670.740.590.90.8
0.20.010.060.2-0.420.070.440.870.43-0.06-0.3-0.230.31-0.260.15-0.36-0.07-0.45-0.610.290.070.080.5-0.150.15
-0.420.51-0.04-0.420.46-0.75-0.380.29-0.14-0.87-0.92-0.790.31-0.87-0.15-0.95-0.30.540.35-0.33-0.36-0.38-0.37-0.87-0.45
0.7-0.250.040.7-0.480.870.62-0.450.430.930.940.87-0.26-0.870.420.910.48-0.7-0.460.610.750.750.570.980.73
0.590.530.440.59-0.220.530.6-0.180.720.340.240.320.15-0.150.420.120.63-0.51-0.10.710.710.610.410.440.61
0.55-0.54-0.070.55-0.530.790.47-0.380.130.920.970.84-0.36-0.950.910.120.3-0.58-0.410.410.460.540.480.920.58
0.640.520.840.63-0.450.610.49-0.170.70.510.480.64-0.07-0.30.480.630.3-0.47-0.10.680.680.630.430.520.66
-0.890.18-0.14-0.90.85-0.91-0.96-0.25-0.75-0.84-0.68-0.7-0.450.54-0.7-0.51-0.58-0.470.87-0.87-0.75-0.82-0.95-0.8-0.88
-0.70.390.16-0.70.78-0.68-0.8-0.49-0.56-0.65-0.49-0.5-0.610.35-0.46-0.1-0.41-0.10.87-0.64-0.49-0.61-0.87-0.56-0.66
0.970.210.350.97-0.720.870.930.10.890.710.590.710.29-0.330.610.710.410.68-0.87-0.640.840.910.840.690.97
0.850.290.230.85-0.460.770.79-0.290.80.680.590.670.07-0.360.750.710.460.68-0.75-0.490.840.950.70.750.86
0.960.120.160.96-0.630.840.88-0.20.750.760.670.740.08-0.380.750.610.540.63-0.82-0.610.910.950.820.780.96
0.89-0.170.110.89-0.910.810.970.320.680.750.570.590.5-0.370.570.410.480.43-0.95-0.870.840.70.820.680.87
0.78-0.280.090.78-0.620.940.72-0.310.490.980.960.9-0.15-0.870.980.440.920.52-0.8-0.560.690.750.780.680.8
1.00.060.261.0-0.770.920.93-0.030.780.820.720.80.15-0.450.730.610.580.66-0.88-0.660.970.860.960.870.8
Click cells to compare fundamentals

Beijing Scitop Account Relationship Matchups

Beijing Scitop fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets466.0M999.2M1.0B1.8B1.8B974.0M
Other Current Liab7.7M5.8M21.5M36.9M1.4M1.4M
Total Current Liabilities63.7M64.4M62.5M85.3M58.6M72.0M
Total Stockholder Equity399.8M932.6M967.4M1.7B1.7B894.5M
Other Liab2.4M2.2M3.5M2.2M2.0M2.4M
Net Tangible Assets377.3M911.9M911.3M1.6B1.9B2.0B
Retained Earnings164.4M261.0M288.0M323.4M323.8M206.1M
Accounts Payable42.5M46.3M27.3M36.4M16.1M27.0M
Cash100.2M202.3M481.8M875.4M191.6M283.1M
Non Current Assets Total217.0M232.0M288.1M463.6M854.5M897.3M
Non Currrent Assets Other11.3M3.4M13.6M159.8M414.8M435.5M
Other Assets6.2M1.7M6.3M162.2M186.6M195.9M
Net Receivables107.5M119.9M115.1M103.3M65.4M79.4M
Non Current Liabilities Total2.4M2.2M10.9M8.7M18.5M19.4M
Inventory30.2M44.7M52.8M50.9M39.2M43.3M
Other Current Assets10.5M6.2M7.0M10.5M498.2M523.1M
Total Liab66.1M66.7M73.3M94.0M77.1M79.4M
Deferred Long Term Liab1.4M667.9K283.8K106.3K95.6K90.9K
Total Current Assets249.0M767.2M752.6M1.3B955.6M648.2M
Intangible Assets20.6M18.8M54.2M53.0M51.1M35.7M
Property Plant Equipment185.8M208.4M213.2M243.9M280.5M163.5M
Net Invested Capital399.8M932.6M967.4M1.7B1.7B993.2M
Net Working Capital185.3M702.8M690.1M1.2B896.9M635.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Beijing Stock

Balance Sheet is a snapshot of the financial position of Beijing Scitop Bio at a specified time, usually calculated after every quarter, six months, or one year. Beijing Scitop Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Beijing Scitop and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Beijing currently owns. An asset can also be divided into two categories, current and non-current.